Pfizer RSV vaccine lags GSK’s as head-to-head competition underway

Malaysia News News

Pfizer RSV vaccine lags GSK’s as head-to-head competition underway
Malaysia Latest News,Malaysia Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 97%

Pfizer (PFE.N), which dominated COVID vaccine sales, now finds itself looking up at GSK (GSK.L), whose rival new respiratory syncytial virus (RSV) vaccine has surged to an early lead since the shots launched this summer.

View of Pfizer's new respiratory syncytial virus vaccine Abrysvo during its manufacture in this undated handout picture. Pfizer/Handout via REUTERS/File photo, whose rival new respiratory syncytial virus vaccine has surged to an early lead since the shots launched this summer.

Price may also be playing a role, according to independent pharmacists. GSK's lists at a slight discount. Link said CVS is the nation's largest retail buyer of pharmaceuticals and "they get a better price by consolidating their purchases."Both companies hope vaccine sales will help offset lost revenue as older medicines like Pfizer's breast cancer treatment Ibrance and GSK’s HIV drug Dovato begin facing generic competition later this decade.

GSK declined to discuss its RSV vaccine contracts, but said customer relationships gives it a competitive advantage. At $280 per shot, the list price for GSK's Arexvy is $15 lower than Pfizer's list for Abrysvo. That price does not represent any volume-based discounts larger chains may receive.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer RSV vaccine lags GSK’s as head-to-head competition underwayPfizer RSV vaccine lags GSK’s as head-to-head competition underwayPfizer RSV vaccine lags GSK’s as head-to-head competition underway
Read more »

RSV vaccine shortage for babies: What parents need to know to keep infants safeRSV vaccine shortage for babies: What parents need to know to keep infants safeThe CDC has announced limited availability of Sanofi immunization Beyfortus for RSV prevention in infants. Here's what parents should know to keep babies safe.
Read more »

Earnings playbook: Your guide to trading another busy week of reports, including Apple and PfizerEarnings playbook: Your guide to trading another busy week of reports, including Apple and PfizerAbout 30% of the S&P 500 is set to report earnings this week, brining the reporting past the halfway mark.
Read more »

Fed Meeting, Jobs Report, Apple Earnings, and More to Watch This WeekFed Meeting, Jobs Report, Apple Earnings, and More to Watch This WeekThe Fed meeting ends on Wednesday and jobs numbers are due on Friday. Plus, third-quarter earnings from Apple, Caterpillar, AMD, Pfizer, Starbucks, PayPal,...
Read more »

Fed Meeting, Jobs Report, Apple Earnings, and MoreFed Meeting, Jobs Report, Apple Earnings, and MoreThe Fed meeting ends on Wednesday and jobs numbers are due on Friday. Plus, third-quarter earnings from Apple, Caterpillar, AMD, Pfizer, Starbucks, PayPal,...
Read more »

Pfizer RSV vaccine lags GSK’s as head-to-head competition underwayPfizer RSV vaccine lags GSK’s as head-to-head competition underwayPfizer RSV vaccine lags GSK’s as head-to-head competition underway
Read more »



Render Time: 2025-02-26 18:19:12